using glp 1 New Guidelines on GLP-1 Drugs for Obesity Released New Study Finds Use of

Join us for a fabulous Botox Party on November 7 at our West Haven location (761 Campbell Avenue) from 6 to 8 p.m

This healing effect is observed in various models of corneal injury, including perforating corneal incisions

Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome a clinical research center study

Thus far it appears to me that the signals are on the positive side, meaning that these drugs seem to be pretty safe as we follow them over increasing amounts of time. ******* Ralph A

The Food and Drug Administration (FDA) has approved three GLP-1s for obesity-related treatment, including Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)